Page 7 - Sam Gandy News Today

Newly published safety data shows that 41 percent of patients in key clinical trials of the Alzheimer’s drug experienced brain bleeding or swelling, though many cases were asymptomatic.

Follow the StarTribune for the news, photos and videos from the Twin Cities and beyond.

Biogen research chief says misinformation is cause for controversy surrounding newly approved Alzheimers drug Dr Alfred Sandrock, head of research and development at Biogen, published a letter combatting misinformation surrounding its drug, Aduhelm  He says that debate over whether the drug works is normal after FDA accelerated approval Cleveland Clinic and Mount Sinai both said they will not administer the controversial drug to patients Aduhelm received FDA approval last month despite little...

Filed to:aducanumab alzheimers diseasebiogenclinical trialfederal assistance in the united statesfood and drug administrationhealth medical pharmahealthcare reform in the united statesjanet woodcockkaiser family foundationkatie porterlife sciencesmedicaidmedicarepresidency of lyndon b johnsonsam gandythe centers for medicare and medicaid services Photo: Matthew Simmons, Getty Images Parts of the medical world are continuing to rebel against Aduhelm, the controversial treatment developed by Biog...

Mass General Brigham unlikely to recommend Alzheimer’s drug to patients on blood thinners Jonathan Saltzman © Provided by The Boston Globe More than a third of patients who took Aduhelm in clinical trials had small brain bleeds or an accumulation of fluid detected by MRI. Mass General Brigham is unlikely to offer Biogen’s controversial new Alzheimer’s drug to patients taking blood thinners because of concerns about the risk of bleeding in the brain, according to two doc...

5 Min Read (Reuters) -Biogen Inc’s Alzheimer’s drug, the first new treatment for the memory-robbing disease in nearly 20 years, hit new barriers on Thursday with some large hospitals declining to use it and health insurers delaying a decision while awaiting coverage terms from Medicare. FILE PHOTO: Aduhelm, Biogens controversial recently approved drug for early Alzheimers disease, is seen at Butler Hospital, one of the clinical research sites in Providence, Rhode Island, U.S. June 16, 2021....

© Reuters. FILE PHOTO: Aduhelm, Biogen’s recently approved controversial drug for early Alzheimer’s disease, is seen at Butler Hospital in one of the clinical research sites conducted on June 16, 2021 in Providence, Rhode Island, USA. Via Jessica Rinaldi / Pool REUTERS Deena by Beasley (Reuters) – Biogen Inc.’s Alzheimer’s drug, the first new treatment for the disease to steal memory for nearly 20 years, hit new hurdles on Thursday as some hospitals refused to use it and health insur...

Published: 8:15 AM May 25, 2021    Sam Gandy and Ben Bell are pictured after completing their 68 mile challenge in aid of Mind - Credit: Submitted Two Norfolk men have completed nearly three marathons in a row to raise funds for a mental health charity close to their hearts. Ben Bell, 30, and Sam Gandy, 34, who are from Norwich and Ludham, ran just under 68 miles on treadmills in the space of 16 hours in aid of Mind.  The charity is personally important to Mr Bell after his own struggles wi...

outsourcing. i want some insourcing. i want to bring companies back. >> oh, beautiful, for spacious skies -- >> the presidents campaign also issued a new attack add mocking romneys stinging and accusing him of sending jobs overseas. >> the ad drew a tough response from the romney campaign every day the statement said president obama hits a new low. >> romney relaxed at his lake house with family today, but yesterday denied the outsourcing claim. >> in several interviews, concluding one...

boiled over with the presidents campaign and mitt romneys accusing each other of lying about romneys record at the helm of bain capital. the fight is notable for how personal and antagonistic it has become nearly four months before voters cast the ballots in the presidential election. >> wyatt andrews is in washington tonight with more on what the president said today and who, if anyone, is telling the whole truth, wyatt. >> reporter: nancy, despite mitt romneys personal demand for an ...